SCHEMBL1077396

SCHEMBL1077396

CC1(C)OC[C@@H](CCl)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1204186 1.00
SCHEMBL150257 1.00
SCHEMBL13875821 0.82
SCHEMBL7154999 0.80 CA2 (0.50)
SCHEMBL14501495 0.80 CA2 (0.55)
SCHEMBL740693 0.80
SCHEMBL18817541 0.80 CA2 (0.50)
SCHEMBL4135508 0.80
SCHEMBL6125258 0.80
Hydrochloric Acid SCHEMBL27847677 0.78 CA2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112062754-B Preparation method of intermediate for synthesizing Dorzagliatin 深圳市华先医药科技有限公司 2022-06-21 CN claimed
CN-112062754-A Preparation method of intermediate for synthesizing Dorzagliatin 深圳市华先医药科技有限公司 2020-12-11 CN claimed
CN-105315255-B A kind of synthetic method of resolving agent hydrogen phthalic acid isopropylidene glyceride 上海予利生物科技股份有限公司 2017-12-26 CN claimed
CN-105315255-A Synthetic method of resolving agent hydrogen isopropylidene glycerol phthalate SHANGHAI YURLIC CHEMICAL S&T CO LTD 2016-02-10 CN claimed
WO-1996029325-A1 HOMOCHIRAL COMPOUNDS FOR THE PREPARATION OF KETOCONAZOLE, TERCONAZOLE AND RELATED ANTIFUNGAL DRUGS LABORATORIOS MENARINI S.A. (ES) 1996-09-26 WO claimed
US-20250263399-A1 CBL-B MODULATORS AND USES THEREOF SCHRÖDINGER, INC. 2025-08-21 US disclosed
US-12325697-B2 CBL-B modulators and uses thereof NIMBUS CLIO, INC. (US) 2025-06-10 US disclosed
US-12275727-B2 Compound containing structure of a five-membered heteroaromatic ring, pharmaceutical compositions thereof and applications thereof 280 BIO, INC. (US) 2025-04-15 US disclosed
CN-114163437-B Substituted pyrazolo [1,5-a ] pyridine compounds as RET kinase inhibitors 阿雷生物药品公司 2025-03-04 CN disclosed
EP-4488275-A1 COMPOUND CONTAINING FIVE-MEMBERED HETEROAROMATIC RING STRUCTURE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Yingli Pharmaceutical Co., Ltd (CN) 2025-01-08 EP disclosed
US-11998545-B2 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors ARRAY BIOPHARMA INC. (US) 2024-06-04 US disclosed
CN-117858707-A CBL-B modulators and uses thereof 林伯士克莱奥公司 2024-04-09 CN disclosed
WO-2008079814-A2 MAPK/ERK KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-03 WO disclosed
WO-2007085540-A1 1H-INDAZ0L-4-YL-2 , 4-PYRIMIDINEDIAMINE DERIVATIVES GLAXO GROUP LIMITED (GB) 2007-08-02 WO disclosed
US-20070161787-A1 C-glycoside derivatives and salts thereof ASTELLAS PHARMA INC. (JP) 2007-07-12 US disclosed
US-7202350-B2 C-glycoside derivatives and salts thereof ASTELLAS PHARMA INC. (JP) 2007-04-10 US disclosed
US-20060122126-A1 C-glycoside derivatives and salts thereof ASTELLAS PHARMA INC. (JP) 2006-06-08 US disclosed
EP-1609785-A1 C-GLYCOSIDE DERIVATIVES AND SALTS THEREOF Astellas Pharma Inc. (JP) 2005-12-28 EP disclosed
WO-2004046118-A2 2-4-(DI-PHENYL-AMINO)-PYRIMIDINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-06-03 WO disclosed
WO-1996029325-A1 HOMOCHIRAL COMPOUNDS FOR THE PREPARATION OF KETOCONAZOLE, TERCONAZOLE AND RELATED ANTIFUNGAL DRUGS LABORATORIOS MENARINI S.A. (ES) 1996-09-26 WO disclosed